Literature DB >> 9137843

How do the currently used prophylactic agents work in migraine?

P J Goadsby1.   

Abstract

Since migraine attacks are often frequent they require management with agents that reduce their number. Such agents, although often effective, are mechanistically ill-understood. They have been suggested to work through four main mechanisms, 5HT2 antagonism, modulation of plasma protein extravasation, modulation of central aminergic control mechanisms and membrane stabilizing effects through actions at voltage-sensitive channels. The evidence for these mechanisms, except plasma protein extravasation (see Cutrer, this supplement) is examined in the light of current thoughts concerning the pathophysiology of migraine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137843     DOI: 10.1046/j.1468-2982.1997.1702085.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

Review 1.  Central mechanism of action of antimigraine prophylactic drugs.

Authors:  Gerardo Casucci; Veronica Villani; Fabio Frediani
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 2.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

3.  Feverfew for preventing migraine.

Authors:  Barbara Wider; Max H Pittler; Edzard Ernst
Journal:  Cochrane Database Syst Rev       Date:  2015-04-20

4.  Antiepileptic Drug Therapy in Migraine Headache.

Authors:  Steve D. Wheeler
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

5.  Prophylactic Therapy for Migraine.

Authors:  Shazia Afridi; Holger Kaube
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

Review 6.  A practical guide to the management and prevention of migraine.

Authors:  H C Diener; H Kaube; V Limmroth
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

7.  Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.

Authors:  Nicholas J Delva; Deborah L Brooks; Michael Franklin; Khalid al-Said; Emily R Hawken; Zul Merali; J Stuart Lawson; Arun V Ravindran
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

Review 8.  Treatment of childhood headaches.

Authors:  A Gupta; A D Rothner
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

Review 9.  Antidepressants in the treatment of migraine headache.

Authors:  Nestor C Punay; James R Couch
Journal:  Curr Pain Headache Rep       Date:  2003-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.